Overview
Tiapride is a selective D2 and D3 dopamine receptor blocker in the brain.
Background
Tiapride is a selective D2 and D3 dopamine receptor blocker in the brain.
Indication
Tiapride is indicated for the treatment of a variety of neurological and psychiatric disorders including dyskinesia, alcohol withdrawal syndrome, negative symptoms of psychosis, and agitation and aggression in the elderly.
Associated Conditions
- Behavioural Disorders
- Chorea
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2015/03/02 | Phase 3 | Terminated | |||
2011/12/29 | Phase 3 | Completed | |||
2008/03/11 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Tiapride Hydrochloride Tablets | 国药准字H32026019 | 化学药品 | 片剂 | 9/2/2020 | |
| Tiapride Hydrochloride Tablets | 国药准字H37023862 | 化学药品 | 片剂 | 4/13/2020 | |
| Tiapride Hydrochloride Tablets | 国药准字H42022731 | 化学药品 | 片剂 | 7/8/2020 | |
| Tiapride Hydrochloride Tablets | 国药准字H23022748 | 化学药品 | 片剂 | 5/27/2020 | |
| Tiapride Hydrochloride Tablets | 国药准字H37023801 | 化学药品 | 片剂 | 9/10/2020 | |
| Tiapride Hydrochloride Tablets | 国药准字H42022783 | 化学药品 | 片剂 | 6/10/2020 | |
| Tiapride Hydrochloride Tablets | 国药准字H37023748 | 化学药品 | 片剂 | 3/30/2020 | |
| Tiapride Hydrochloride Tablets | 国药准字H37023603 | 化学药品 | 片剂 | 4/17/2020 | |
| Tiapride Hydrochloride Tablets | 国药准字H32026217 | 化学药品 | 片剂 | 9/2/2020 | |
| Tiapride Hydrochloride Tablets | 国药准字H11022155 | 化学药品 | 片剂 | 7/19/2022 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||